A Study of LY3867070 in Healthy Participants
Phase 1
196
about 1.3 years
18–65
2 sites in CA, TX
About this study
This trial is testing a new medication called LY3867070 in healthy people. The goal is to see if the medication is safe and what side effects might occur. Blood tests will be done to understand how the body processes the medication.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take LY3867070
- 2.Take Placebo
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Primary: Number of Participants with One or More Adverse Event(s) (AEs) Considered by the Investigator to be Related to Study Drug Administration, Number of Participants with One or More Serious Adverse Event(s) (SAEs) Considered by the Investigator to be Related to Study Drug Administration, Number of Participants with One or More Treatment Emergent Adverse Events (TEAEs) Considered by the Investigator to be Related to Study Drug Administration
Secondary: PK: Maximum Concentration (Cmax) of LY3867070, Part B Pharmacodynamic (PD): Change from Baseline in Gene Expression, Pharmacokinetics (PK): Area Under the Concentration Versus Time Curve (AUC) of LY3867070